BiomX Inc.
PHGE
$4.98
-$0.06-1.19%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 82.35% | -0.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.71% | 14.84% | |||
| Operating Income | 15.71% | -14.84% | |||
| Income Before Tax | -45.54% | -51.83% | |||
| Income Tax Expenses | -66.67% | 50.00% | |||
| Earnings from Continuing Operations | -45.51% | -51.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.51% | -51.83% | |||
| EBIT | 15.71% | -14.84% | |||
| EBITDA | 17.18% | -2.16% | |||
| EPS Basic | -20.23% | -51.39% | |||
| Normalized Basic EPS | 74.84% | -51.39% | |||
| EPS Diluted | -20.23% | -51.39% | |||
| Normalized Diluted EPS | 74.84% | -51.39% | |||
| Average Basic Shares Outstanding | 21.02% | 0.29% | |||
| Average Diluted Shares Outstanding | 21.02% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||